Share This

Topics Comments

  Next page > 
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
IPO 2024-12-26T12:01 財經茄呢啡 「不出意外,銀行後續上市進程有望穩步推進。」投行人士稱,透過聆訊表明該行已經透過了港交所對其上市資格、業務可持續性、合規性等方面的詳細審查,是一個積極信號,但還需完成路演、招股等後續步驟,最終才能正式掛牌上市。
IPO 2024-12-26T12:01 財經茄呢啡 圖達通曾於2023年8月透過證監會IPO備案,但遲遲未能完成上市;此外,該公司還曾計劃向美國SEC遞交招股書擬登陸納斯達克。上述交易,將助力其透過TECHSTAR曲線在香港聯交所上市。
IPO 2024-12-26T12:01 財經茄呢啡 隨著港股IPO的回暖,百利天恆( 688506.SH )、康樂衛士、恆瑞醫藥等多家A股醫藥企業紛紛發布赴港第二IPO計劃,而如今已實現「A+H」兩地上市的生物醫藥企業約20家。今年11月以來,軒竹生物、翰思艾泰、華芢生物、維立志博、銀諾醫藥等生物醫藥公司先後向港交所遞交招股書,預估明年港股將再度迎來醫藥企業上市熱潮。
IPO 2024-12-26T12:01 財經茄呢啡 12月20日,廣東金晟新能源股權有限公司(簡稱「金晟新能源」)在港交所遞交招股書,擬在香港IPO上市,中金公司、招銀國際為聯席保薦人。
IPO 2024-12-26T12:01 財經茄呢啡 格隆匯獲悉,近日,紐曼思健康食品控股有限公司(簡稱「紐曼思」)透過港交所上市聆訊,接下來很可能會招股上市。
IPO 2024-12-06T12:11 財經茄呢啡 土著部分接獲8210份申請,涉及3億8175萬股,超額認購48.28倍。其他公眾部分則接到8461分申請,認購5億4300萬股,超額認購69.1倍。
IPO 2024-12-06T12:11 財經茄呢啡 預期本月16日上市的明亮眼科專科中心配合首次公開售股(IPO)活動供公眾認購的新股,取得超額認購58.69倍。
IPO 2024-12-06T12:11 財經茄呢啡 土著投資者部分則共收到8,210份申請,認購3.82億股,超額認購48.28倍;其他公眾申請有8,461份,申購5.43億股,超額認購69.1倍。
IPO 2024-12-06T12:11 財經茄呢啡 土著部分取得8210份申請,認購3億8174萬9700股,超額認購48.28倍;而公眾部分則接獲8461份申請,認購5億4300萬6400股,超額認購為69.19倍。
IPO 2024-12-06T12:11 財經茄呢啡 即將在12月16日轉戰馬股創業板的眼科醫療中心明亮眼科專科中心(TOPVISN,03013,LEAP板醫療保健)首發股反應熱烈,獲超額認購58.69倍。
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.